Viridian Therapeutics Inc. VRDN
$16.15
▲ +1.30% 24H
About
Viridian Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing best-in-class medicines for patients with autoimmune and rare diseases, particularly thyroid eye disease (TED). The company leverages expertise in antibody discovery and protein engineering t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees252
TickerVRDN
Statistics
Market Cap$1.65B
Revenue (TTM)$70.8M
Net Income-$342.6M
Net Margin-483.6%
EPS—
P/E-4.96
P/S24.56
P/B3.21
EV/EBITDA-2.72
ROE-58.1%
Dividend Yield—
Price$16.15
Data: Twelve Data · Revenue = mcap / P/S